Cargando...
Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing
Zoledronic acid (ZA) is a potential immunotherapy for cancer because it can induce potent γδ T-cell-mediated anti-tumour responses. Clinical trials are testing the efficacy of intravenous ZA in cancer patients; however, the effects of systemic ZA on the activation and migration of peripheral γδ T ce...
Gardado en:
| Publicado en: | Immunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4253502/ https://ncbi.nlm.nih.gov/pubmed/24912747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12331 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|